The Luteal Phase After GnRHa Trigger - a Proof of Concept Study.
Phase of Trial: Phase IV
Latest Information Update: 01 Oct 2015
At a glance
- Drugs Choriogonadotropin alfa (Primary) ; Follitropin alfa (Primary) ; Lutropin alfa (Primary) ; Estradiol; Progesterone
- Indications Female infertility; Hot flashes; Menopausal syndrome; Ovulation disorders; Vasomotor symptoms
- Focus Pharmacodynamics; Proof of concept
- 05 Jun 2013 Planned End Date changed from 1 Mar 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 29 May 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 09 Jan 2012 New trial record